quinazolines has been researched along with gw 583340 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aird, KM; Devi, GR; Ghanayem, RB; Lyerly, HK; Peplinski, S | 1 |
| Aird, KM; Allensworth, JL; Batinic-Haberle, I; Devi, GR; Dewhirst, MW; Lyerly, HK | 1 |
| Chen, JJ; Chen, ZS; Patel, A; Singh, S; Sodani, K; Sun, YL; Talele, TT; Tiwari, AK; Xiao, ZJ | 1 |
3 other study(ies) available for quinazolines and gw 583340
| Article | Year |
|---|---|
X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Breast Neoplasms; Carcinoma; Cells, Cultured; Down-Regulation; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; ErbB Receptors; Feasibility Studies; Female; Gene Expression Regulation, Neoplastic; Humans; Mastitis; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Sulfones; X-Linked Inhibitor of Apoptosis Protein | 2010 |
ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells.
Topics: Antioxidants; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; ErbB Receptors; Female; Glutathione; Humans; Inflammatory Breast Neoplasms; Membrane Potential, Mitochondrial; Oxidative Stress; Quinazolines; Reactive Oxygen Species; Receptor, ErbB-2; Sulfones; Superoxide Dismutase | 2012 |
GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Models, Molecular; Neoplasm Proteins; Quinazolines; Receptor, ErbB-2; Sulfones | 2012 |